With Timetable In Hand And Icahn On Board, Bausch Health Looks To ‘Expedite Spin-Off’

Executives say Bausch + Lomb spin-out preparations will be completed by the end of Q3. When asked, they elaborated on Carl Icahn’s acquisition of 27.8m shares, for a 7.8% stake, and expansion of the firm’s board by two seats for Icahn’s representatives.

Bausch Health company logo icon on tablet screen

Bausch Health Companies Inc. has a timetable for being ready to divest its Bausch + Lomb business and new board members representing activist investor Carl Icahn who “align” with the plan.

Executives elaborated on their spin-out plan, saying preparations will be completed by the end of the third quarter, on 24...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Deals

More from Business